A prospective, open-label, interventional study protocol to evaluate treatment efficacy of nivolumab based on serum-soluble PD-L1 concentration for patients with metastatic and unresectable renal cell carcinoma.
Yukari BandoNobuyuki HinataTakashi OmoriMasato FujisawaPublished in: BMJ open (2019)
UMIN000027873.